ATAI AtaiBeckley Inc.

$7.35▲ +0.00% Healthcare Other
After hours $7.33▼ -0.27% Sep 10, 7:30 PM ET
Volume 9.55M Avg Volume (10D) 19.92M
Key Metrics & Fundamentals
Market Cap
$2.73B
P/E Ratio
–
Div Yield
–%
52W Range
3.27 - 7.45
% vs 50 MA
7.32%
% vs 200 MA
55.76%
RSI-14
61.8
MACD Histogram
-0.0500
Beta (1Y vs SPY)
1.25
Free Cash Flow
-$35.27M
Gross Rev
$1.70M
Gross Profit
$1.70M
EBITDA
-$42.26M
COGS
–
Operating Exp
$43.43M
Operating Income
-$41.72M
EBIT
-$41.72M
Pretax Income
-$32.48M
Net Income
-$32.52M
EPS (Diluted)
-0.09
Price & Volume History
Loading chart…
Recent News
Eli Lilly Completes Acquisition of AtaiBeckley
MT Newswires · Sep 11, 2026 1:23 PM
Why Is AtaiBeckley Inc (ATAI) Up 0.8% Since Last Earnings Report?
Zacks · Sep 10, 2026 3:30 PM
Eli Lilly Strikes $2.88 Billion Deal to Buy Merida Biosciences
MT Newswires · Aug 31, 2026 2:52 PM
Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion
The Wall Street Journal · Aug 31, 2026 11:24 AM
3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now
Simply Wall St. · Aug 21, 2026 5:16 AM
Wall Street Analysts Predict a 31.48% Upside in AtaiBeckley Inc (ATAI): Here's What You Should Know
Zacks · Aug 7, 2026 1:55 PM
Eli Lilly Stock: The One Question in Otherwise Perfect Earnings and What It Means for Shares
Barrons.com · Aug 5, 2026 5:43 PM
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · Aug 2, 2026 10:26 PM
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
IPO-Edge.com · Jul 22, 2026 5:25 PM
How Much Upside is Left in AtaiBeckley Inc (ATAI)? Wall Street Analysts Think 33.33%
Zacks · Jul 22, 2026 1:55 PM
Financial Overview - Income Statement Quarterly

See ATAI's money flow as a full page

Social Sentiment
Avg +0.76 · 21 posts
NewsDiscussionBig Pharma wants psychedelics?
r/wallstreetbets · Jul 17, 2026
The post expresses interest in ATAI due to Eli Lilly's investment and broader psychedelics sector optimism.
positive +0.70
NewsDDEli Lilly Jumps Into Psychedelic Medicine with Well Timed Acquisition of AtaiBeckley
r/StockMarket · Jul 16, 2026
The post highlights a key product (BPL-003) and strategic move for Atai, indicating potential growth.
positive +0.60
TradeDiscussionATAI is the ticker, run it up
r/wallstreetbets · Jul 16, 2026
The post encourages running up the stock price, indicating bullish sentiment towards ATAI.
positive +0.80
NewsDiscussionTradeFact Sheet: President Donald J. Trump is Accelerating Medical Treatments for Serious Mental Illness
r/wallstreetbets · Apr 19, 2026
The post expresses a bullish outlook on Atai based on Trump's approval of psychedelic therapies.
positive +0.70
NewsDiscussionTrump just signed an EO to fast-track psychedelics. ATAI ($1.4B) and GHRS ($1.04B) are Phase 3-ready with FDA Breakthrough designations.
r/wallstreetbets · Apr 18, 2026
AtaiBeckley is highlighted as a key beneficiary of the FDA's fast-tracking initiative.
very_positive +1.00
Page 1 of 5 (21 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙